Taro Pharmaceutical Industries Price on December 31, 2023
TARODelisted Stock | USD 42.97 0.00 0.00% |
If you're considering investing in Taro Stock, it is important to understand the factors that can impact its price. As of today, the current price of Taro Pharmaceutical stands at 42.97, as last reported on the 30th of November, with the highest price reaching 42.98 and the lowest price hitting 42.89 during the day. We have found seven technical indicators for Taro Pharmaceutical Industries, which you can use to evaluate the volatility of the company. Please validate Taro Pharmaceutical's Price Action Indicator of 0.035, accumulation distribution of 0.0021, and Day Typical Price of 42.95 to confirm if the risk estimate we provide is consistent with the expected return of 0.0%.
Taro Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
Taro |
Sharpe Ratio = 0.0
Best Portfolio | Best Equity | |||
Good Returns | ||||
Average Returns | ||||
Small Returns | ||||
Cash | Small Risk | Average Risk | High Risk | Huge Risk |
TARO |
Based on monthly moving average Taro Pharmaceutical is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Taro Pharmaceutical by adding Taro Pharmaceutical to a well-diversified portfolio.
Taro Pharmaceutical Valuation on December 31, 2023
It is possible to determine the worth of Taro Pharmaceutical on a given historical date. On December 31, 2023 Taro was worth 42.06 at the beginning of the trading date compared to the closed value of 41.78. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Taro Pharmaceutical stock. Still, in general, we apply an absolute valuation method to find Taro Pharmaceutical's value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Taro Pharmaceutical where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Taro Pharmaceutical's related companies.
Open | High | Low | Close | Volume | |
42.07 | 42.11 | 41.51 | 41.76 | 28,068 | |
12/29/2023 | 42.06 | 42.42 | 41.55 | 41.78 | 24,066 |
41.45 | 41.85 | 41.26 | 41.76 | 28,783 |
Backtest Taro Pharmaceutical | | | Taro Pharmaceutical History | | | Taro Pharmaceutical Valuation | Previous | Next |
Taro Pharmaceutical Trading Date Momentum on December 31, 2023
On January 02 2024 Taro Pharmaceutical Industries was traded for 41.76 at the closing time. The top price for the day was 41.85 and the lowest listed price was 41.26 . The trading volume for the day was 28.8 K. The trading history from January 2, 2024 was a factor to the next trading day price decrease. The trading price change against the next closing price was 0.05% . The trading price change against the current closing price is 0.48% . |
Taro Pharmaceutical Fundamentals Correlations and Trends
By evaluating Taro Pharmaceutical's financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Taro Pharmaceutical's main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Taro financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Taro Pharmaceutical Stock history
Taro Pharmaceutical investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Taro is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Taro Pharmaceutical will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Taro Pharmaceutical stock prices may prove useful in developing a viable investing in Taro Pharmaceutical
Taro Pharmaceutical Industries Ltd., a science-based pharmaceutical company, develops, manufactures, and markets prescription and over-the-counter pharmaceutical products in the United States, Canada, Israel, and internationally. Taro Pharmaceutical Industries Ltd. is a subsidiary of Alkaloida Chemical Company Exclusive Group Ltd. Taro Pharm operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on New York Stock Exchange. It employs 1455 people.
Taro Pharmaceutical Stock Technical Analysis
Taro Pharmaceutical technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, delisted stock market cycles, or different charting patterns.
Price Boundaries
Taro Pharmaceutical Period Price Range
Low | November 30, 2024
| High |
0.00 | 0.00 |
Taro Pharmaceutical Industries cannot be verified against its exchange. Please verify the symbol is currently traded on New York Stock Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Taro Pharmaceutical November 30, 2024 Market Strength
Market strength indicators help investors to evaluate how Taro Pharmaceutical stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Taro Pharmaceutical shares will generate the highest return on investment. By undertsting and applying Taro Pharmaceutical stock market strength indicators, traders can identify Taro Pharmaceutical Industries entry and exit signals to maximize returns
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the Insider Screener module to find insiders across different sectors to evaluate their impact on performance.
Other Consideration for investing in Taro Stock
If you are still planning to invest in Taro Pharmaceutical check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Taro Pharmaceutical's history and understand the potential risks before investing.
Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
FinTech Suite Use AI to screen and filter profitable investment opportunities | |
Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets |